Modeling chimeric antigen receptor response at the single-cell level with conditional optimal transport

Alice Driessen1, Jannis Born2, Rocio Castellanos Rueda3

  • 1IBM Research Europe, Zurich, Switzerland; Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland.

Cell Systems
|April 23, 2026
PubMed

Insights

This study introduces an optimal transport framework to predict responses to chimeric antigen receptor (CAR) T cell therapy at the single-cell level. The model accurately predicts gene expression changes and generalizes to novel CAR designs for improved cancer immunotherapy.

Area of Science:

  • Immunology
  • Computational Biology
  • Bioinformatics

Background:

  • Chimeric antigen receptor (CAR) T cell therapy shows promise for cancer treatment but faces challenges in clinical efficacy.
  • Current computational models struggle to capture cellular heterogeneity and generalize to new CAR variants.

Purpose of the Study:

  • To develop a computational framework for predicting CAR T cell therapy responses at the single-cell level.
  • To enable the rational design of novel CARs by elucidating CAR design-function relationships.

Main Methods:

  • An optimal transport (OT)-based framework was developed to predict CAR expression responses.
  • Protein language models were used to embed CARs, extending the framework to a conditional OT-based model.
  • The model was evaluated for its ability to capture gene expression changes and generalize to unseen CAR variants.

Main Results:

  • The OT-based model accurately captures gene expression changes across diverse CAR variants.
  • The model outperforms baseline methods for in-distribution CARs and reflects biological characteristics.
  • The conditional OT-based model successfully generalizes predictions to out-of-distribution CAR designs.

Conclusions:

  • Optimal transport-based modeling is valuable for understanding CAR design-function relationships.
  • This framework facilitates the rational design of novel CARs with therapeutic potential.
  • The developed model enhances the prediction of CAR T cell therapy responses.

Related Concept Videos